IFOSFAMIDE
NDC 10019-925, IFOSFAMIDE, injection, powder, for solution, from Baxter Healthcare Company.
- Product NDC
- 10019-925
- Status
- Listed
- Labeler
- Baxter Healthcare Company
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA019763
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10019-925 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IFOSFAMIDE1 g/20mL
Pharmacologic classes
Alkylating Activity [MoA]; Alkylating Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10019-925-01 | 10019092501 | 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-925-01) / 20 mL in 1 VIAL, SINGLE-DOSE (10019-925-82) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/91e433a9-6800-43a6-ac13-a49a04a5aecdMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=10019-925
Use it
Look up 10019-925 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10019-925 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10019-925. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.